Thank you to our speakers, sponsors, and delegates who joined us in
San Diego for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com
In 2025, the 3rd Spatial Biology for Immuno-Oncology Summit offered a unique platform for you and your peers to address the industry's most pressing challenges. Our attendees engaged with global experts from Pathology, Computational Biology, Bioinformatics, and Translation to uncover practical case studies that showcased the successful application of spatial biology in immuno-oncology.
At this industry-focused forum, we learned from leaders already harnessing spatial technologies to develop cutting-edge solutions and enhance drug development workflows. These conversations shaped the future of oncology.
What Was New for 2025?
We utilized spatial technologies to generate comprehensive tissue expression profiles, enabling precise spatial mapping of molecular targets with Johnson & Johnson
We distilled biological insights from complex spatial omics data using data analytics techniques with Eli Lilly & Co.
We explored how spatial data informs key decisions on balancing evidence generation with the costs of drug development, identifying when and how much to invest for optimal outcomes with Amgen
We assessed the strengths and weaknesses of building external and internal spatial biology capabilities to ensure informed resource allocation with AbbVie & Pfizer
We leveraged AI techniques for identifying complex patterns and relationships within spatial data with Genentech
As spatial biology rapidly integrates into immuno-oncology, it is fundamentally reshaping our understanding of tumor-immune interactions. Recent breakthroughs in imaging and molecular profiling technologies are providing unprecedented insights into the tumor microenvironment (TME), enabling researchers to identify critical immune subpopulations and discover novel biomarkers with remarkable precision. This transformative approach not only enhances our understanding of cancer biology but also paves the way for the development of more effective and personalized immunotherapies.
As we stand at the forefront of this transformation, critical questions still persist:
How Do We Integrate Spatial Data Into Clinical Workflows?
How Can Organizations Create a Business Case for These Innovations That Is Both Cost-Effective and Time-Efficient?
What Computational Tools Are Necessary to Decode Complex Datasets?
2025 Expert Speakers Snapshot
Jack Chen
Director - Scientific, Precision Medicine, Immuno-Oncology & Translational Research Group Lead
Abbvie
The Trusted Industry Forum For
What Your Peers Thought
“There was a tremendous amount of interaction and engagement between the audience and speakers. It had a wonderful think tank atmosphere” MEI Pharma
“Open discussion with honest insights, some leaders in the field really speak up for the true issues and potential solution, enjoyed the whole thing, it is very valuable for the whole community!” Pfizer
“The content and agenda were very solid. I enjoyed interacting with peers and sharing our work” AbbVie
“Excellent collection of speakers, great opportunities for networking” Arcus Biosciences
“Wide perspective on the entire field of spatial biology with a high level of science and technology covered” Takeda